WallachBeth Announces Pricing Of FBS Global Initial Public Offering
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that FBS Global Limited ("FBS Global" or the "Company"),(NASDAQ: FBGL) a green building contractor with award-winning projects using green construction methods and sustainably-source and environmentally responsible materials based in Singapore,
Titan America Initial Public Offering Priced Toward Low End of Views
Titan America's initial public offering was priced toward the low end of expectations, giving the U.S. arm of Belgian cement producer Titan Cement International an initial market value of about $2.95 billion.
Titan America Announces Pricing of Initial Public Offering
Titan America SA (“Titan America”), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, today priced its initial
EPWK HOLDINGS LTD. Announces Pricing of Initial Public Offering
EPWK HOLDINGS LTD. (the 'Company') (NasdaqGM: EPWK), a company that connects businesses with great talents through innovative and efficient cloud-sourcing platforms, announced the pricing of its initial public offering (the 'Offering') of 2,
Sionna Therapeutics Prices Upsized Initial Public Offering
Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein,
Sionna Therapeutics prices upsized IPO at $18 per share
Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis—Sionna Therapeutics (SION) priced its upsized initial public offering of ~10.59M shares at $18.
FBS Global Limited Announces Pricing of Initial Public Offering
WallachBeth Capital LLC is acting as the sole book-running manager of the Offering. TroyGould PC is acting as U.S. counsel to the Company, and Ortoli Rosenstadt LLP is acting as U.S. securities counsel to WallachBeth Capital LLC in connection with the Offering.
IPO watch 2025: these two restaurant chains may go public next
Twin Peaks – an American chain of sports bars and restaurants goes live on Nasdaq in what is the first restaurant debut of the new year on Thursday. The company’s debut holds significance as it could ...
Brazil chemical firm Unigel to go public in Singapore, media report says
SAO PAULO (Reuters) -Brazilian chemical firm Unigel will launch an initial public offering (IPO) in Singapore in the next few months, Brazilian newspaper Valor Economico reported on Thursday, citing ...
Huachen AI Parking Management Technology Holding Co., Ltd Announces Closing of Initial Public Offering
Huachen AI Parking Management Technology Holding Co., Ltd (the "Company") (NASDAQ: HCAI), a comprehensive smart parking solutions and equipment structural parts provider with all operations through ...
Sports bar chain Twin Peaks is going public. These restaurant companies are the next to watch
IPO experts are expecting more companies to go public this year than last year, and restaurants including Panera and Fogo de Chao are considering offerings.
Quantum licensee Celly Nutrition announces exploration of public offering
BioPharma announced that its licensee Celly Nutrition Corporation, the company behind unbuzzd announced that it has engaged a leading New York ...
Nasdaq6d
Beta Bionics, Inc. Closes Upsized Initial Public Offering Raising Approximately $229.1 Million
Beta Bionics, Inc. has successfully completed an upsized initial public offering, closing on 13.8 million shares of common stock at $17.00 per share, including an option for underwriters to ...
Winklevoss Twins’ Crypto Exchange Gemini Is Said to Weigh IPO
Gemini, the cryptocurrency firm backed by the billionaire Winklevoss twins, is considering an initial public offering as soon ...
Swiss biotech BioVersys gets $235 million valuation after completing flotation
Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...